What You Should Know:
- Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences.
- The strategic acquisition will integrate Nortis's advanced Kidney-on-Chip technology into Quris-AI's Bio-AI platform, enhancing its ability to predict drug safety and efficacy in humans.
Combining Cutting-Edge Technologies
Nortis's Kidney-on-Chip models have been
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Lindus Health Launches “All-in-One Women’s Health CRO” to Accelerate Clinical Trials
What You Should Know:
- Lindus Health, a leading innovator in clinical trial solutions, has announced the launch of its "All-in-One Women's Health CRO" offering.
- The comprehensive suite of services and technology is specifically designed to support the unique needs of companies developing treatments and diagnostics for women's health conditions.
Addressing the Unique Challenges of Women's Health Research
Clinical trials for women's health products require specialized
Read More
The Double-Edged Sword of GenAI in the Life Sciences Sector
It’s said that data is the lifeblood of the modern enterprise. While that’s certainly true, it’s also true that there is perhaps no industry as dependent on data – and protecting it – as the life sciences sector.
Of course, the very nature of data has evolved significantly over the past few years. What once consisted of straightforward records and research results has now expanded to include highly complex and distributed datasets generated by advanced technologies like genomics, AI-driven
Read More
Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring
What You Should Know:
- Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
- The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD).
Addressing the Challenges of Advanced Heart Failure
Heart
Read More
Pangea and Knight Cancer Institute collab to advance precision oncology for metastatic cancer
What You Should Know:
- Pangea Biomed, the startup behind the advanced cancer response prediction platform ENLIGHT, today announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University (OHSU).
- This collaboration will explore the ability to predict personalized cancer treatment response using data processed through the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Clinical Trials
Read More
How A Human-AI Partnership Can Boost Clinical Trial Recruitment
The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already challenging process of finding clinical trial participants.
Because trial sponsors are struggling to find sufficient numbers of suitable participants, 80% of the world’s more than 450,000 clinical trials are at risk of
Read More
Combining an Omnichannel Strategy with Benchmarking and Metrics to Engage Healthcare Professionals
A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). A brand can best meet its clinical and commercial objectives throughout its lifecycle by offering a well-orchestrated mix of information and resources in different digital and in-person formats that HCPs can easily access.
As with any multifaceted marketing and commercialization strategy, brand
Read More
ixlayer Launches At-Home CBC Testing for Direct-to-Patient Biopharma Programs
What You Should Know:
- xlayer, the leading cloud-based platform powering an end-to-end direct-to-patient (DTP) healthcare experience, announced availability of a Complete Blood Count (CBC) test with at-home sample collection. This move supports biopharma partners who want to accelerate virtual care and reduce barriers to care for patients.
- Available through ixEngage, ixlayer’s DTP biopharma solution, biopharma companies can develop programs to include a CBC test,
Read More
Ontada Transforms Unstructured Oncology Data with Microsoft Azure AI
What You Should Know:
- Ontada, a McKesson business specializing in oncology real-world data and evidence, has formed a strategic partnership with Microsoft to leverage the power of Azure AI in transforming cancer care.
- The partnership will harness the capabilities of Azure OpenAI Service to efficiently process vast amounts of unstructured oncology data, unlocking valuable insights and ultimately improving patient outcomes.
The Challenge of Unstructured Data in
Read More
Phenomix Sciences, InformedDNA Integrate to Advance Genetics-Driven Obesity Care
What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.
- The collaboration integrates Phenomix’s MyPhenomeTM genetic obesity test with InformedDNA’s DNAimpactTM precision health platform, broadening access to genetics-based weight management care for
Read More
